Pacific Biosciences Of California (PACB) Enterprise Value Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.98% |
| Dec 31, 2025 | 28.74% |
| Sep 30, 2025 | 0.67% |
| Jun 30, 2025 | 60.57% |
| Mar 31, 2025 | 29.10% |
| Dec 31, 2024 | 27.99% |
| Jun 30, 2024 | 39.90% |
| Mar 31, 2024 | 15.56% |
| Dec 31, 2023 | -97.11% |
| Sep 30, 2023 | -22.77% |
| Jun 30, 2023 | -90.54% |
| Mar 31, 2023 | -35.42% |
| Dec 31, 2022 | -195.51% |
| Sep 30, 2022 | -83.64% |
| Jun 30, 2022 | -137.82% |
| Mar 31, 2022 | -126.48% |
| Dec 31, 2021 | -116.90% |
| Jun 30, 2021 | -93.51% |
| Mar 31, 2021 | -127.50% |
| Dec 31, 2020 | -9.46% |
| Sep 30, 2020 | -35.43% |
| Jun 30, 2020 | -5.35% |
| Mar 31, 2020 | -36.51% |
| Dec 31, 2019 | 25.36% |
| Sep 30, 2019 | 17.41% |
| Jun 30, 2019 | 13.27% |
| Mar 31, 2019 | 3.26% |
| Dec 31, 2018 | -7.55% |
| Sep 30, 2018 | -25.25% |
| Jun 30, 2018 | 4.40% |
| Mar 31, 2018 | -0.05% |
| Dec 31, 2017 | 14.71% |
| Sep 30, 2017 | 5.44% |
| Jun 30, 2017 | 0.78% |
| Mar 31, 2017 | 22.14% |
| Dec 31, 2016 | 13.84% |
| Sep 30, 2016 | 11.72% |
| Jun 30, 2016 | 1.42% |
| Mar 31, 2016 | -19.95% |
| Dec 31, 2015 | 6.48% |
| Sep 30, 2015 | 16.72% |
| Jun 30, 2015 | 6.17% |
| Mar 31, 2015 | 21.13% |
| Dec 31, 2014 | 17.03% |
| Sep 30, 2014 | 30.08% |
| Jun 30, 2014 | 24.41% |
| Mar 31, 2014 | -11.96% |
| Dec 31, 2013 | 30.04% |
| Sep 30, 2013 | -26.49% |
| Jun 30, 2013 | -5.87% |